Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

The role of tumor suppressor of resveratrol and prednisolone by downregulation of YKL-40 expression in CCRF-CEM cell line.

Zadi Heydarabad M, Baharaghdam S, Azimi A, Mohammadi H, Eivazi Ziaei J, Yazdanpanah B, Zak MS, Farahani ME, Dohrabpour A, Partash N, Talebi M.

J Cell Biochem. 2018 Nov 13. doi: 10.1002/jcb.27659. [Epub ahead of print]

PMID:
30426549
2.

Phenotypic and molecular detection of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates from patients with burns in Tehran, Iran.

Azimi A, Peymani A, Pour PK.

Rev Soc Bras Med Trop. 2018 Sep-Oct;51(5):610-615. doi: 10.1590/0037-8682-0174-2017.

3.

Enhanced validation of antibodies for research applications.

Edfors F, Hober A, Linderbäck K, Maddalo G, Azimi A, Sivertsson Å, Tegel H, Hober S, Szigyarto CA, Fagerberg L, von Feilitzen K, Oksvold P, Lindskog C, Forsström B, Uhlen M.

Nat Commun. 2018 Oct 8;9(1):4130. doi: 10.1038/s41467-018-06642-y.

4.

Association of nod-like receptor protein-3 single nucleotide gene polymorphisms and expression with the susceptibility to relapsing-remitting multiple sclerosis.

Imani D, Azimi A, Salehi Z, Rezaei N, Emamnejad R, Sadr M, Izad M.

Int J Immunogenet. 2018 Dec;45(6):329-336. doi: 10.1111/iji.12401. Epub 2018 Sep 28.

PMID:
30264444
5.

An analytical enrichment-based review of structural genetic studies on keratoconus.

Panahi Y, Azimi A, Naderi M, Jadidi K, Sahebkar A.

J Cell Biochem. 2018 Sep 27. doi: 10.1002/jcb.27764. [Epub ahead of print]

PMID:
30260013
6.

Tape Stripped Stratum Corneum Samples Prove to be Suitable for Comprehensive Proteomic Investigation of Actinic Keratosis.

Azimi A, Ali M, Kaufman KL, Mann GJ, Fernandez-Penas P.

Proteomics Clin Appl. 2018 Sep 24:e1800084. doi: 10.1002/prca.201800084. [Epub ahead of print]

PMID:
30247810
7.

Evaluating the relationship between emotional intelligence and cognitive disorders in patients with Multiple Sclerosis.

Owji M, Sahraian MA, Bidadian M, Ghadiri F, Etesam F, Azimi A, Moghadasi AN.

Iran J Neurol. 2018 Apr 4;17(2):78-81.

8.

Evaluation of the risk of cervical cancer in patients with Multiple Sclerosis treated with cytotoxic agents: A cohort study.

Doosti R, Togha M, Moghadasi AN, Aghsaie A, Azimi AR, Khorramnia S, Moinfar Z, Ensani F, Harirchian MH, Minagar A, Sahraian MA.

Iran J Neurol. 2018 Apr 4;17(2):64-70.

9.

Chemometrics analysis of petroleum hydrocarbons sources in the street dust, runoff and sediment of urban rivers in Anzali port - South of Caspian Sea.

Azimi A, Bakhtiari AR, Tauler R.

Environ Pollut. 2018 Dec;243(Pt A):374-382. doi: 10.1016/j.envpol.2018.08.073. Epub 2018 Aug 30.

PMID:
30199812
10.

Evaluation of BAX and BCL-2 Gene Expression and Apoptosis Induction in Acute Lymphoblastic Leukemia Cell Line CCRFCEM after High- Dose Prednisolone Treatment

Ghasemi A, Khanzadeh T, Zadi Heydarabad M, Khorrami A, Jahanban Esfahlan A, Ghavipanjeh S, Gholipour Belverdi M, Darvishani Fikouhi S, Darbin A, Najafpour M, Azimi A.

Asian Pac J Cancer Prev. 2018 Aug 24;19(8):2319-2323.

11.

Apoptotic effect of resveratrol on human T-ALL cell line CCRF-CEM is unlikely exerted through alteration of BAX and BCL2 promoter methylation.

Zadi Heydarabad M, Vatanmakanian M, Abdolalizadeh J, Mohammadi H, Azimi A, Mousavi Ardehaie R, Movasaghpour A, Farshdousti Hagh M.

J Cell Biochem. 2018 Dec;119(12):10033-10040. doi: 10.1002/jcb.27333. Epub 2018 Aug 21.

PMID:
30132966
12.

Intravitreal Injection of Bevacizumab: Review of our previous Experience.

Afarid M, Sadegi Sarvestani A, Rahat F, Azimi A.

Iran J Pharm Res. 2018 Summer;17(3):1093-1098.

13.

Polo-like kinases and acute leukemia.

Goroshchuk O, Kolosenko I, Vidarsdottir L, Azimi A, Palm-Apergi C.

Oncogene. 2018 Aug 13. doi: 10.1038/s41388-018-0443-5. [Epub ahead of print] Review.

PMID:
30104712
14.

The prevalence, incidence and familial recurrence of multiple sclerosis in Tehran, Iran.

Eskandarieh S, Molazadeh N, Moghadasi AN, Azimi AR, Sahraian MA.

Mult Scler Relat Disord. 2018 Oct;25:143. doi: 10.1016/j.msard.2018.07.023. Epub 2018 Jul 17. No abstract available.

PMID:
30075407
15.

Pain in Patients with Multiple Sclerosis.

Ghajarzadeh M, Jalilian R, Sahraian MA, Moghadasi AN, Azimi A, Mohammadifar M, Azizi S.

Maedica (Buchar). 2018 Jun;13(2):125-130. doi: 10.26574/maedica.2018.13.2.125.

16.

Anteromedial GPi deep brain stimulation in Tourette syndrome: The first case series from Iran.

Azimi A, Parvaresh M, Shahidi G, Habibi A, Rohani S, Safdarian M, Fattahi A, Taheri M, Rohani M.

Clin Neurol Neurosurg. 2018 Sep;172:116-119. doi: 10.1016/j.clineuro.2018.06.045. Epub 2018 Jul 4.

PMID:
29990958
17.

Prevalence and predictors of dysphagia in Iranian patients with multiple sclerosis.

Tarameshlu M, Azimi AR, Ghelichi L, Ansari NN.

Med J Islam Repub Iran. 2017 Dec 26;31:133. doi: 10.14196/mjiri.31.133. eCollection 2017.

18.

The effects of amantadine on traumatic brain injury outcome: a double-blind, randomized, controlled, clinical trial.

Ghalaenovi H, Fattahi A, Koohpayehzadeh J, Khodadost M, Fatahi N, Taheri M, Azimi A, Rohani S, Rahatlou H.

Brain Inj. 2018;32(8):1050-1055. doi: 10.1080/02699052.2018.1476733. Epub 2018 May 23.

PMID:
29790790
19.

Anti-JC virus antibody sera positivity and index value among patients with multiple sclerosis may be correlated with age, sex, and area of residence.

Koolaji S, Allahabadi NS, Ahmadi A, Eskandarieh S, Moghadasi AN, Azimi AR, Sahraian MA.

J Neurovirol. 2018 Oct;24(5):570-576. doi: 10.1007/s13365-018-0646-0. Epub 2018 May 21.

PMID:
29785581
20.

Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection.

Azizi H, Mirzaeei H, Nasiri AA, Bazi A, Mirzapour A, Khatami M, Nahavandi KH, Azimi A, Yaghoobi H.

Exp Parasitol. 2018 Jun;189:66-71. doi: 10.1016/j.exppara.2018.04.015. Epub 2018 Apr 27.

PMID:
29729492
21.

Intraocular Lens Calcification: Clinico-pathological Report of Two Cases and Literature Review.

Rahimi M, Azimi A, Hosseinzadeh M.

J Ophthalmic Vis Res. 2018 Apr-Jun;13(2):195-199. doi: 10.4103/jovr.jovr_36_16.

22.

Distribution of Hepatitis C Virus Genotypes in Patients with Major β-Thalassemia in Mashhad, Northeast Iran.

Ahmadi-Ghezeldasht S, Badiei Z, Sima HR, Hedayati-Moghaddam MR, Habibi M, Khamooshi M, Azimi A.

Middle East J Dig Dis. 2018 Jan;10(1):35-39. doi: 10.15171/mejdd.2017.88. Epub 2018 Jan 7.

23.

Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.

Azimi A, Kaufman KL, Ali M, Arthur J, Kossard S, Fernandez-Penas P.

J Dermatol Sci. 2018 Jul;91(1):69-78. doi: 10.1016/j.jdermsci.2018.04.006. Epub 2018 Apr 10.

PMID:
29665991
24.

Investigation of BAX and BCL2 expression and apoptosis in a resveratrol- and prednisolone-treated human T-ALL cell line, CCRF-CEM.

Khanzadeh T, Hagh MF, Talebi M, Yousefi B, Azimi A, Hossein Pour Feizi AA, Baradaran B.

Blood Res. 2018 Mar;53(1):53-60. doi: 10.5045/br.2018.53.1.53. Epub 2018 Mar 27.

25.

Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors.

Azimi A, Caramuta S, Seashore-Ludlow B, Boström J, Robinson JL, Edfors F, Tuominen R, Kemper K, Krijgsman O, Peeper DS, Nielsen J, Hansson J, Egyhazi Brage S, Altun M, Uhlen M, Maddalo G.

Mol Syst Biol. 2018 Mar 5;14(3):e7858. doi: 10.15252/msb.20177858.

26.

Environmental risk factors in neuromyelitis optica spectrum disorder: a case-control study.

Eskandarieh S, Nedjat S, Abdollahpour I, Azimi AR, Moghadasi AN, Asgari N, Sahraian MA.

Acta Neurol Belg. 2018 Jun;118(2):277-287. doi: 10.1007/s13760-018-0900-5. Epub 2018 Mar 2.

27.

Convergent effects of a functional C3 variant on brain atrophy, demyelination, and cognitive impairment in multiple sclerosis.

Roostaei T, Sadaghiani S, Mashhadi R, Falahatian M, Mohamadi E, Javadian N, Nazeri A, Doosti R, Naser Moghadasi A, Owji M, Hashemi Taheri AP, Shakouri Rad A, Azimi A, Voineskos AN, Nazeri A, Sahraian MA.

Mult Scler. 2018 Feb 1:1352458518760715. doi: 10.1177/1352458518760715. [Epub ahead of print]

PMID:
29485352
28.

A Survey on Mental Health Status of Adult Population Aged 15 and above in the Province of Ardebil, Iran.

Noorbala AA, Bagheri Yazdi SA, Faghihzadeh S, Kamali K, Faghihzadeh E, Hajebi A, Akhondzadeh S, Sedighnia A, Azimi A.

Arch Iran Med. 2017 Nov 1;20(11 Suppl. 1):S11-S14.

PMID:
29481118
29.

Regulatory effect of resveratrol and prednisolone on MDR1 gene expression in acute lymphoblastic leukemia cell line (CCRF-CEM): An epigenetic perspective.

Zadi Heydarabad M, Nikasa M, Vatanmakanian M, Azimi A, Farshdousti Hagh M.

J Cell Biochem. 2018 Jun;119(6):4890-4896. doi: 10.1002/jcb.26709. Epub 2018 Feb 26.

PMID:
29377275
30.

Mental Health and Victimization: Does Risky Lifestyle Matter?

Azimi AM, Daigle LE.

J Interpers Violence. 2017 Aug 1:886260517724255. doi: 10.1177/0886260517724255. [Epub ahead of print]

PMID:
29294883
31.

α-Lipoic acid, functional fatty acid, as a novel therapeutic alternative for central nervous system diseases: A review.

Seifar F, Khalili M, Khaledyan H, Amiri Moghadam S, Izadi A, Azimi A, Shakouri SK.

Nutr Neurosci. 2017 Nov 29:1-11. doi: 10.1080/1028415X.2017.1386755. [Epub ahead of print]

PMID:
29185388
32.

Long-term prognosis of patients with non-ST-segment elevation myocardial infarction according to coronary arteries atherosclerosis extent on coronary angiography: a historical cohort study.

Alzuhairi KS, Søgaard P, Ravkilde J, Azimi A, Mæng M, Jensen LO, Torp-Pedersen C.

BMC Cardiovasc Disord. 2017 Nov 16;17(1):279. doi: 10.1186/s12872-017-0710-3.

33.

Neuromyelitis optica spectrum disorders in Iran.

Eskandarieh S, Nedjat S, Azimi AR, Moghadasi AN, Sahraian MA.

Mult Scler Relat Disord. 2017 Nov;18:209-212. doi: 10.1016/j.msard.2017.10.007. Epub 2017 Oct 9.

PMID:
29141812
34.

Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations.

Sahraian MA, Moghadasi AN, Azimi AR, Asgari N, H Akhoundi F, Abolfazli R, Alaie S, Ashtari F, Ayromlou H, Baghbanian SM, Moghadam NB, Fatehi F, Foroughipour M, Langroodi HG, Majdinasab N, Nickseresht A, Nourian A, Shaygannejad V, Torabi HR.

Mult Scler Relat Disord. 2017 Nov;18:144-151. doi: 10.1016/j.msard.2017.09.015. Epub 2017 Sep 25. Review.

PMID:
29141797
35.

Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin.

Azimi A, Majidinia M, Shafiei-Irannejad V, Jahanban-Esfahlan R, Ahmadi Y, Karimian A, Mir SM, Karami H, Yousefi B.

Gene. 2018 Feb 5;642:249-255. doi: 10.1016/j.gene.2017.11.008. Epub 2017 Nov 7.

PMID:
29126924
36.

Pattern Visual Evoked Potentials in Dyslexic Children.

Shandiz JH, Heyrani M, Sobhani-Rad D, Salehinejad Z, Shojaei S, Khoshsima MJ, Azimi A, Yekta AA, Yazdi SHH.

J Ophthalmic Vis Res. 2017 Oct-Dec;12(4):402-406. doi: 10.4103/jovr.jovr_106_16.

37.

Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells.

Azimi A, Tuominen R, Costa Svedman F, Caramuta S, Pernemalm M, Frostvik Stolt M, Kanter L, Kharaziha P, Lehtiö J, Hertzman Johansson C, Höiom V, Hansson J, Egyhazi Brage S.

Cell Death Dis. 2017 Aug 31;8(8):e3029. doi: 10.1038/cddis.2017.406.

38.

Balaglitazone reverses P-glycoprotein-mediated multidrug resistance via upregulation of PTEN in a PPARγ-dependent manner in leukemia cells.

Yousefi B, Azimi A, Majidinia M, Shafiei-Irannejad V, Badalzadeh R, Baradaran B, Zarghami N, Samadi N.

Tumour Biol. 2017 Oct;39(10):1010428317716501. doi: 10.1177/1010428317716501.

PMID:
28978268
39.

Effect of alpha-lipoic acid on asymmetric dimethylarginine and disability in multiple sclerosis patients: A randomized clinical trial.

Khalili M, Soltani M, Moghadam SA, Dehghan P, Azimi A, Abbaszadeh O.

Electron Physician. 2017 Jul 25;9(7):4899-4905. doi: 10.19082/4899. eCollection 2017 Jul.

40.

Polyostotic craniofacial fibrous dysplasia with bizarre radiologic finding: Mandible, anterior skull base, frontal, temporal, parietal, and occipital bones involvement.

Tabibkhooei A, Taheri M, Rohani S, Azimi A.

Surg Neurol Int. 2017 Aug 1;8:160. doi: 10.4103/sni.sni_87_17. eCollection 2017. No abstract available.

41.

Evaluation of Emergency Department Management of Opioid-Tolerant Cancer Patients With Acute Pain.

Patel PM, Goodman LF, Knepel SA, Miller CC, Azimi A, Phillips G, Gustin JL, Hartman A.

J Pain Symptom Manage. 2017 Oct;54(4):501-507. doi: 10.1016/j.jpainsymman.2017.07.013. Epub 2017 Jul 17.

PMID:
28729010
42.

Cross-cultural adaption and validation of the Persian version of the SWAL-QOL.

Tarameshlu M, Azimi AR, Jalaie S, Ghelichi L, Ansari NN.

Medicine (Baltimore). 2017 Jun;96(26):e7254. doi: 10.1097/MD.0000000000007254.

43.

The expression of VDR mRNA but not NF-κB surprisingly decreased after vitamin D treatment in multiple sclerosis patients.

Shirvani-Farsani Z, Kakhki MP, Gargari BN, Doosti R, Moghadasi AN, Azimi AR, Behmanesh M.

Neurosci Lett. 2017 Jul 13;653:258-263. doi: 10.1016/j.neulet.2017.05.050. Epub 2017 May 30.

PMID:
28576565
44.

IVS-II-648/649 (-T) (HBB: c.316-202del) Triggers a Novel β-Thalassemia Phenotype.

Azimi A, Alibakhshi R, Hayati H, Tahmasebi S, Alimoradi S.

Hemoglobin. 2017 Jan;41(1):44-46. doi: 10.1080/03630269.2017.1308376. Epub 2017 May 5.

PMID:
28475449
45.

Perinatal outcome in pregnancy with polyhydramnios in comparison with normal pregnancy in department of obstetrics at Shiraz University of Medical Sciences.

Asadi N, Khalili A, Zarei Z, Azimi A, Kasraeian M, Foroughinia L, Salehi A, Ravanbod HR, Davoodi S, Vafaei H.

J Matern Fetal Neonatal Med. 2018 Jul;31(13):1696-1702. doi: 10.1080/14767058.2017.1325864. Epub 2017 May 22.

PMID:
28462606
46.

Effects of walnut oil on lipid profiles in hyperlipidemic type 2 diabetic patients: a randomized, double-blind, placebo-controlled trial.

Zibaeenezhad MJ, Farhadi P, Attar A, Mosleh A, Amirmoezi F, Azimi A.

Nutr Diabetes. 2017 Apr 10;7(4):e259. doi: 10.1038/nutd.2017.8.

47.

Hypothesis: ROBOPHERA, a phosphatase and tensin homolog-targeted antineoplastic therapy.

Azimi A, Azimi A.

Anticancer Drugs. 2017 Apr;28(4):369-375. doi: 10.1097/CAD.0000000000000476. Review.

PMID:
28301379
48.

Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control study.

Eskandarieh S, Nedjat S, Abdollahpour I, Moghadasi AN, Azimi AR, Sahraian MA.

Mult Scler Relat Disord. 2017 Feb;12:39-43. doi: 10.1016/j.msard.2017.01.004. Epub 2017 Jan 6.

PMID:
28283104
49.
50.

Could "calprotectin" and "endocan" serve as "Troponin of Nephrologists"?

Azimi A.

Med Hypotheses. 2017 Feb;99:29-34. doi: 10.1016/j.mehy.2016.12.008. Epub 2016 Dec 19.

PMID:
28110693

Supplemental Content

Support Center